Kalaris Therapeutics, Inc.
KLRS
$4.16
$0.081.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 97.22M | 117.98M | 77.00M | 88.43M | 100.97M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 861.00K | 827.00K | 1.18M | 3.23M | 1.22M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 389.00K | -- | -- | -- | -- |
| Total Current Assets | 98.47M | 118.81M | 78.18M | 91.65M | 102.18M |
|
|
|||||
| Total Current Assets | 98.47M | 118.81M | 78.18M | 91.65M | 102.18M |
| Net Property, Plant & Equipment | 1.43M | 1.48M | 1.52M | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.25M | 1.45M | 1.48M | 1.19M | 910.00K |
| Total Assets | 109.81M | 121.74M | 81.18M | 92.84M | 103.09M |
|
|
|||||
| Total Accounts Payable | 905.00K | 1.28M | 494.00K | 3.68M | 2.37M |
| Total Accrued Expenses | 6.86M | 8.12M | 5.20M | 3.83M | 4.54M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 317.00K | 316.00K | 376.00K | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 142.00K | 230.00K |
| Total Other Current Liabilities | -- | -- | -- | 142.00K | 230.00K |
| Total Current Liabilities | 8.08M | 9.71M | 6.07M | 7.65M | 7.14M |
|
|
|||||
| Total Current Liabilities | 8.08M | 9.71M | 6.07M | 7.65M | 7.14M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.09M | 1.13M | 1.17M | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 32.08M | 32.08M | 32.08M | 32.08M | 32.08M |
| Total Liabilities | 41.25M | 42.92M | 39.31M | 39.73M | 39.22M |
|
|
|||||
| Common Stock & APIC | 239.46M | 238.81M | 191.86M | 191.22M | 190.63M |
| Retained Earnings | -170.86M | -160.00M | -150.00M | -138.11M | -126.76M |
| Treasury Stock & Other | -49.00K | 6.00K | 6.00K | -- | -- |
| Total Common Equity | 68.56M | 78.81M | 41.87M | 53.12M | 63.87M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 68.56M | 78.81M | 41.87M | 53.12M | 63.87M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 68.56M | 78.81M | 41.87M | 53.12M | 63.87M |
|
|
|||||